首页> 外文期刊>Vaccine >The realities of biodefense vaccines against Rickettsia. (Special Issue: Vaccines for biodefense.)
【24h】

The realities of biodefense vaccines against Rickettsia. (Special Issue: Vaccines for biodefense.)

机译:抵抗立克次氏体的生物防御疫苗的现实。 (特刊:生物防御疫苗。)

获取原文
获取原文并翻译 | 示例
           

摘要

Rickettsia prowazekii, R. rickettsii, R. conorii, and R. typhi are serious biologic weapon threats because of high infectivity of low dose aerosols, stable small particle aerosol infectivity, virulence causing severe disease, difficulty in establishing a timely diagnosis, ineffectiveness of usual empiric treatments, potential for engineered complete antimicrobial resistance, lower level of immunity, availability of the agents in nature, and feasibility of propagation, stabilization, and dispersal. Infection induces long-term immunity, killed rickettsial vaccines stimulate incomplete protection, and a live attenuated mutant stimulates strong immunity but reverts to virulence. Prospects for rational development of a safe, effective live attenuated vaccine are excellent.
机译:Rickettsia prowazekii , R。 rickettsii , R。 conorii 和 R。伤寒是严重的生物武器威胁,因为低剂量气雾剂具有较高的传染性,稳定的小颗粒气溶胶传染性,致病性致病性强,难以及时诊断,常规经验性治疗无效,具有工程化的完全耐药性,免疫力较低,自然界中药物的有效性以及繁殖,稳定和分散的可行性。感染会诱导长期免疫,杀死的立克次氏体疫苗会激发不完全的保护,而减毒活突变株会激发较强的免疫力,但会恢复为毒力。合理开发安全,有效的减毒活疫苗的前景非常好。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号